| scholarly article | Q13442814 |
| P2093 | author name string | de Jong PT | |
| Mooy CM | |||
| Sharma HS | |||
| Kliffen M | |||
| Kerkvliet S | |||
| P2860 | cites work | Element analysis of the early stages of age-related macular degeneration | Q28284496 |
| Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis | Q29617644 | ||
| Growth factor responsiveness of human retinal pigment epithelial cells | Q30454158 | ||
| Retinal pigment epithelial cells produce PDGF-like proteins and secrete them into their media | Q30460352 | ||
| Ageing and degeneration in the macular region: a clinico-pathological study | Q33649685 | ||
| Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins | Q33775844 | ||
| Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages | Q33908328 | ||
| Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. | Q34062411 | ||
| Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. | Q34292373 | ||
| Transforming growth factor type beta induces monocyte chemotaxis and growth factor production | Q34339289 | ||
| Blood-ocular barrier breakdown in eyes with ocular melanoma. A potential role for vascular endothelial growth factor/vascular permeability factor | Q35795581 | ||
| Bruch's membrane change with age | Q35898431 | ||
| Some recent advances in the chemistry and biology of transforming growth factor-beta | Q36217584 | ||
| Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. | Q36675534 | ||
| Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light | Q37315189 | ||
| The regulation of blood vessel growth by vascular endothelial growth factor | Q40400770 | ||
| An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group | Q40440695 | ||
| Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. | Q41481649 | ||
| Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration | Q41711674 | ||
| Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration | Q42474273 | ||
| Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture | Q42483851 | ||
| Immunohistochemical light and electron microscopy of basal laminar deposit | Q42498465 | ||
| Analysis of carbohydrate structures in basal laminar deposit in aging human maculae | Q42501654 | ||
| Macrophages related to Bruch's membrane in age-related macular degeneration | Q44289922 | ||
| Basic fibroblast growth factor and local injury protect photoreceptors from light damage in the rat | Q45974666 | ||
| Subcellular localization of bFGF in human retinal pigment epithelium in vitro | Q46115373 | ||
| Identification of glycosaminoglycans in age-related macular deposits. | Q50537417 | ||
| Expression of insulin and insulin-like growth factor receptors and binding proteins by retinal pigment epithelium. | Q52237105 | ||
| Histologic features of the early stages of age-related macular degeneration. A statistical analysis | Q52426498 | ||
| Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. | Q52883818 | ||
| Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. | Q54195980 | ||
| Platelet-derived growth factor gene expression in cultured human retinal pigment epithelial cells | Q67464705 | ||
| Basic Fibroblast Growth Factor Levels in the Vitreous of Patients With Proliferative Diabetic Retinopathy | Q67660782 | ||
| Angiogenesis | Q67897095 | ||
| Prevalence of age-related maculopathy. The Beaver Dam Eye Study | Q68207448 | ||
| Senile macular degeneration: the involvement of immunocompetent cells | Q68934224 | ||
| Pathologic features of senile macular degeneration | Q68935500 | ||
| Retinal pigment epithelial cells release an inhibitor of neovascularization | Q68949295 | ||
| Age-related macular degeneration | Q69037879 | ||
| Evolution of geographic atrophy of the retinal pigment epithelium | Q69099160 | ||
| Correlation between lipids extracted from Bruch's membrane and age | Q70562346 | ||
| Identification of transforming growth factor-beta expressed in cultured human retinal pigment epithelial cells | Q70578667 | ||
| Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells | Q70764129 | ||
| Hypoxic regulation of vascular endothelial growth factor in retinal cells | Q71559437 | ||
| Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases | Q71697254 | ||
| Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study | Q71933360 | ||
| Protein analysis of human maculae in relation to age-related maculopathy | Q71964434 | ||
| Distribution of Growth Factors in Subfoveal Neovascular Membranes in Age-related Macular Degeneration and Presumed Ocular Histoplasmosis Syndrome | Q72026554 | ||
| The prevalence of age-related maculopathy in the Rotterdam Study | Q72560755 | ||
| Angiogenesis inhibition in age-related macular degeneration | Q73211566 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 154-162 | |
| P577 | publication date | 1997-02-01 | |
| P1433 | published in | British Journal of Ophthalmology | Q13443571 |
| P1476 | title | Increased expression of angiogenic growth factors in age-related maculopathy | |
| P478 | volume | 81 |
| Q28076775 | A Historical Analysis of the Quest for the Origins of Aging Macula Disorder, the Tissues Involved, and Its Terminology |
| Q40662746 | A peptide encoded by exon 6 of VEGF (EG3306) inhibits VEGF-induced angiogenesis in vitro and ischaemic retinal neovascularisation in vivo. |
| Q33358094 | A reproducible and quantifiable model of choroidal neovascularization induced by VEGF A165 after subretinal adenoviral gene transfer in the rabbit. |
| Q39706540 | A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization |
| Q37289866 | A systematic review on the effect of bevacizumab in exudative age-related macular degeneration. |
| Q27331651 | Adhesion failures determine the pattern of choroidal neovascularization in the eye: a computer simulation study |
| Q42442066 | Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexes |
| Q33939215 | Aflibercept for the treatment of age-related macular degeneration |
| Q34658699 | Aflibercept: a Potent Vascular Endothelial Growth Factor Antagonist for Neovascular Age-Related Macular Degeneration and Other Retinal Vascular Diseases |
| Q35126780 | Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies |
| Q73738846 | Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction |
| Q43095043 | Alternative therapies in exudative age related macular degeneration. |
| Q35855800 | An apolipoprotein E variant may protect against age-related macular degeneration through cytokine regulation. |
| Q34109862 | An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema |
| Q36222187 | Angiographic results of retinal-retinal anastomosis and retinal-choroidal anastomosis after treatments in eyes with retinal angiomatous proliferation |
| Q33362774 | Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization |
| Q34920676 | Antiangiogenic effects of somatostatin analogues |
| Q48267717 | Aqueous vascular endothelial growth factor and aflibercept concentrations after bimonthly intravitreal injections of aflibercept for age-related macular degeneration. |
| Q44195126 | Aqueous vascular endothelial growth factor and ranibizumab concentrations after monthly and bimonthly intravitreal injections of ranibizumab for age-related macular degeneration |
| Q33368078 | Are intravitreal bevacizumab and ranibizumab effective in a rat model of choroidal neovascularization? |
| Q36249045 | Assessment of Corneal Sensation, Innervation and Retinal Nerve Fiber Layer in Patients Treated with Multiple Intravitreal Ranibizumab Injections |
| Q34543206 | Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism |
| Q43094462 | Bevacizumab treatment for choroidal neovascularization due to age-related macular degeneration in Japanese patients. |
| Q28294611 | Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial |
| Q87623713 | Bimonthly injections of ranibizumab for age-related macular degeneration |
| Q37513330 | Biocompatible reverse thermal gel sustains the release of intravitreal bevacizumab in vivo |
| Q36063372 | Biological Modulation of Mouse RPE Cells in Response to Subthreshold Diode Micropulse Laser Treatment |
| Q36766273 | Blockade of Tumor Necrosis Factor-Alpha: A Role for Adalimumab in Neovascular Age-Related Macular Degeneration Refractory to Anti-Angiogenesis Therapy? |
| Q38767261 | Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases |
| Q36163917 | Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease |
| Q46031089 | Changes in neovascular choroidal morphology after intravitreal bevacizumab injection: prospective trial on 156 eyes throughout 12-month follow-up. |
| Q33840832 | Cigarette smoke-related hydroquinone dysregulates MCP-1, VEGF and PEDF expression in retinal pigment epithelium in vitro and in vivo |
| Q46106778 | Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesis |
| Q48276388 | Combined VEGF and PDGF inhibition for neovascular AMD: anti-angiogenic properties of axitinib on human endothelial cells and pericytes in vitro. |
| Q35162123 | Comparison of bevacizumab and ranibizumab in age-related macular degeneration: a systematic review and meta-analysis |
| Q43052782 | Compassionate use of intravitreal pegaptanib in patients with age-related macular degeneration |
| Q53373714 | Conbercept (KH-902) for the treatment of neovascular age-related macular degeneration. |
| Q44680785 | Cost‐utility analysis of bevacizumab versus ranibizumab in neovascular age‐related macular degeneration using a Markov model |
| Q36841141 | Current smoking is associated with a poor visual acuity improvement after intravitreal ranibizumab therapy in patients with exudative age-related macular degeneration |
| Q37616149 | Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering |
| Q45875184 | Development of Multigenic Lentiviral Vectors for Cell-Specific Expression of Antiangiogenic miRNAs and Protein Factors |
| Q35192906 | Development of gene therapy for treatment of age-related macular degeneration |
| Q44727636 | Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium |
| Q36853843 | Downregulation of p22phox in retinal pigment epithelial cells inhibits choroidal neovascularization in mice |
| Q30724159 | Dynamics of phosphorothioate oligonucleotides in normal and laser photocoagulated retina |
| Q33744652 | Effect of intravitreal injection of ranibizumab on retinal ganglion cells and microvessels in the early stage of diabetic retinopathy in rats with streptozotocin-induced diabetes |
| Q33260828 | Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment |
| Q38814437 | Effects of Bevacizumab on Bcl-2 Expression and Apoptosis in Retinal Pigment Epithelial Cells under Oxidative Stress |
| Q46259787 | Effects of ginkgo biloba extract on cultured human retinal pigment epithelial cells under chemical hypoxia |
| Q30733653 | Efficacy of treatment with ranibizumab in patients with wet age-related macular degeneration in routine clinical care: data from the COMPASS health services research |
| Q48500443 | Elusive drusen and changing terminology of AMD. |
| Q35573134 | Enhanced expression of vascular endothelial growth factor in lungs of newborn infants with congenital diaphragmatic hernia and pulmonary hypertension |
| Q61799608 | Establishing Liposome-Immobilized Dexamethasone-Releasing PDMS Membrane for the Cultivation of Retinal Pigment Epithelial Cells and Suppression of Neovascularization |
| Q44252123 | Evaluation of retrobulbar blood flow by color doppler ultrasonography after intravitreal ranibizumab injection in patients with neovascular age-related macular degeneration |
| Q31931800 | Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat. |
| Q35294211 | Expression of pigment epithelium-derived factor and thrombospondin-1 regulate proliferation and migration of retinal pigment epithelial cells |
| Q40013824 | Expression profile of voltage-dependent Ca2+ channel subunits in the human retinal pigment epithelium |
| Q30773162 | External beam radiotherapy for subretinal neovascularization in age-related macular degeneration: is this treatment efficient? |
| Q48385724 | Extrinsic and intrinsic factors controlling axonal regeneration after spinal cord injury |
| Q43230859 | Functional analysis of platelet-activating factor in the retinal pigment epithelial cells and choroidal endothelial cells |
| Q36470931 | Functional loss in early age-related maculopathy: the ischaemia postreceptoral hypothesis. |
| Q35243299 | Gene profiling of human VEGF signaling pathways in human endothelial and retinal pigment epithelial cells after anti VEGF treatment |
| Q41269839 | Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial |
| Q42236754 | High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration |
| Q37269574 | High-contrast enzymatic immunohistochemistry of pigmented tissues |
| Q37807299 | How to overcome retinal neuropathy: The fight against angiogenesisrelated blindness |
| Q58779270 | Human Vascular Endothelial Growth Factor A Expression Induces the Mouse Model of Neovascular Age-Related Macular Degeneration |
| Q28539266 | IKK2 inhibition attenuates laser-induced choroidal neovascularization |
| Q34207836 | Immunological and aetiological aspects of macular degeneration |
| Q36086191 | Immunological factors in the pathogenesis and treatment of age-related macular degeneration |
| Q39316202 | Implementation studies of ranibizumab for neovascular age-related macular degeneration |
| Q40712203 | Induction of vascular endothelial growth factor by 4-hydroxynonenal and its prevention by glutathione precursors in retinal pigment epithelial cells |
| Q86657869 | Influence of anti-VEGF about cardiovascular biomarkers in age related macular degeneration |
| Q40311774 | Inhibition of ocular angiogenesis by diced small interfering RNAs (siRNAs) specific to vascular endothelial growth factor (VEGF). |
| Q46641527 | Inhibitory effects of verapamil isomers on the proliferation of choroidal endothelial cells |
| Q40692956 | Inhibitory mechanism of vascular endothelial growth factor (VEGF) by bucillamine |
| Q37526810 | Intake of dietary salt and drinking water: Implications for the development of age-related macular degeneration |
| Q39350086 | Interaction between VEGF and calcium-independent phospholipase A2 in proliferation and migration of retinal pigment epithelium. |
| Q28359761 | Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium |
| Q36659514 | Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration. |
| Q35884935 | Intravitreal Topotecan Inhibits Laser-induced Choroidal Neovascularization in a Rat Model. |
| Q46733714 | Intravitreal administration of triamcinolone and bevacizumab for pigment epithelial detachment in conjunction with AMD |
| Q39466620 | Intravitreal aflibercept for neovascular age-related macular degeneration. |
| Q36513804 | Intravitreal aflibercept treatment in eyes with exudative age-related macular degeneration following prior treatment with intravitreal ranibizumab |
| Q46679896 | Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to age-related macular degeneration in an Indian population. |
| Q33529769 | Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy |
| Q48171768 | Intravitreal injection of aflibercept, an anti-VEGF antagonist, down-regulates plasma von Willebrand factor in patients with age-related macular degeneration. |
| Q39545613 | Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas |
| Q37261449 | Klotho regulates retinal pigment epithelial functions and protects against oxidative stress |
| Q39038492 | Light-activated, in situ forming gel for sustained suprachoroidal delivery of bevacizumab |
| Q53195480 | Long-term intraocular pressure changes after intravitreal injection of bevacizumab. |
| Q30249206 | Management of Myopic Choroidal Neovascularization: Focus on Anti-VEGF Therapy |
| Q35909406 | Management of retinal vascular diseases: a patient-centric approach |
| Q44621747 | Modeling of diseases of retinal ischemia in vitro: possible participation of autocrine vascular endothelial growth factor signaling |
| Q33867982 | Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology. |
| Q37273740 | Molecular pathology of age-related macular degeneration |
| Q41373392 | Multigenic lentiviral vectors for combined and tissue-specific expression of miRNA- and protein-based antiangiogenic factors |
| Q39594704 | NBHA reduces acrolein-induced changes in ARPE-19 cells: possible involvement of TGFβ. |
| Q40618965 | Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells |
| Q37882685 | Neovascular age-related macular degeneration: opportunities for development of first-in-class biopharmaceuticals |
| Q35838282 | New Approach of Anti-VEGF Agents for Age-Related Macular Degeneration |
| Q35027712 | Nicotine increases the VEGF/PEDF ratio in retinal pigment epithelium: a possible mechanism for CNV in passive smokers with AMD |
| Q35874689 | One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a comparative analysis based on disease stages |
| Q37391494 | Oxalomalate reduces expression and secretion of vascular endothelial growth factor in the retinal pigment epithelium and inhibits angiogenesis: Implications for age-related macular degeneration |
| Q37801465 | Oxidation and age-related macular degeneration: insights from molecular biology |
| Q90730580 | Oxidative stress-mediated TXNIP loss causes RPE dysfunction |
| Q49918278 | PEDF Expression Affects the Oxidative and Inflammatory State of Choroidal Endothelial Cells |
| Q37134028 | PPAR-alpha Ligands as Potential Therapeutic Agents for Wet Age-Related Macular Degeneration |
| Q36446030 | Peroxisome proliferator-activated receptor and age-related macular degeneration |
| Q38030051 | Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration. |
| Q38301978 | Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys |
| Q37510227 | Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration |
| Q47361893 | Plasma levels of hypoxia-regulated factors in patients with age-related macular degeneration. |
| Q40937602 | Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation |
| Q34151519 | Polymorphisms in the VEGF-A in polypoidal choroidal vasculopathy in a Korean population |
| Q44061379 | Population pharmacokinetics of pegaptanib in patients with neovascular, age-related macular degeneration |
| Q31065469 | Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy |
| Q35884984 | Pre-Analytical Parameters Affecting Vascular Endothelial Growth Factor Measurement in Plasma: Identifying Confounders |
| Q38812551 | Principles of Ocular Pharmacology |
| Q40266023 | Progression of intermediate age-related macular degeneration with proliferation and inner retinal migration of hyperreflective foci |
| Q36512564 | Promising new treatments for neovascular age-related macular degeneration |
| Q37879163 | Radiation treatment for age-related macular degeneration |
| Q38528148 | Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration |
| Q37981760 | Ranibizumab for age-related macular degeneration |
| Q34449898 | Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration. |
| Q36627279 | Ranibizumab: treatment in patients with neovascular age-related macular degeneration |
| Q46429748 | Rapamycin reduces VEGF expression in retinal pigment epithelium (RPE) and inhibits RPE-induced sprouting angiogenesis in vitro |
| Q33541827 | Recombinant human VEGF165b inhibits experimental choroidal neovascularization |
| Q98779139 | Reduced Expression of VEGF-A in Human Retinal Pigment Epithelial Cells and Human Muller Cells Following CRISPR-Cas9 Ribonucleoprotein-Mediated Gene Disruption |
| Q34451693 | Reduction of choroidal neovascularization in mice by adeno-associated virus-delivered anti-vascular endothelial growth factor short hairpin RNA. |
| Q54384743 | Regulation of VEGF expression in human retinal cells by cytokines: implications for the role of inflammation in age-related macular degeneration. |
| Q37336612 | Relationships between clinical measures of visual function and anatomic changes associated with bevacizumab treatment for choroidal neovascularization in age-related macular degeneration |
| Q35819298 | Restoration of mesenchymal retinal pigmented epithelial cells by TGFβ pathway inhibitors: implications for age-related macular degeneration |
| Q45150259 | Results of radiotherapy of subfoveal neovascularization with 16 and 20 Gy. |
| Q37665378 | Resveratrol Suppresses Expression of VEGF by Human Retinal Pigment Epithelial Cells: Potential Nutraceutical for Age-related Macular Degeneration |
| Q46779217 | Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration |
| Q43724459 | Role of Fas-ligand in age-related maculopathy not established |
| Q35611516 | Role of growth factors and the wound healing response in age-related macular degeneration |
| Q36977422 | Role of ranibizumab in management of macular degeneration. |
| Q35300661 | Role of vascular permeability factor/vascular endothelial growth factor in eye disease |
| Q36860915 | Serum VEGF and CFH in exudative age-related macular degeneration |
| Q38543289 | Sub-lytic C5b-9 induces functional changes in retinal pigment epithelial cells consistent with age-related macular degeneration. |
| Q54247660 | Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection. |
| Q30732439 | Suppression of experimental choroidal neovascularization utilizing KDR selective receptor tyrosine kinase inhibitor |
| Q28854271 | Systemic propranolol reduces b-wave amplitude in the ERG and increases IGF-1 receptor phosphorylation in rat retina |
| Q34972210 | Targeting Neovascularization in Ischemic Retinopathy: Recent Advances |
| Q34425420 | Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration |
| Q36911869 | Targeting vascular endothelial growth factor: a promising strategy for treating age-related macular degeneration |
| Q48570003 | The Bowman lecture. Towards an understanding of age-related macular disease |
| Q35892555 | The COX-2-Selective Antagonist (NS-398) Inhibits Choroidal Neovascularization and Subretinal Fibrosis |
| Q58111148 | The Controversial Role of TGF-β in Neovascular Age-Related Macular Degeneration Pathogenesis |
| Q58766295 | The Use of Vascular Endothelial Growth Factor Inhibitors and Complementary Treatment Options in Polypoidal Choroidal Vasculopathy: A Subtype of Neovascular Age-Related Macular Degeneration |
| Q41764457 | The effects of small interfering RNA-targeting tissue factor on an in vitro model of neovascularization |
| Q24532130 | The potential role of amyloid beta in the pathogenesis of age-related macular degeneration |
| Q40061729 | The upregulation of angiogenic gene expression in cultured retinal pigment epithelial cells grown on type I collagen. |
| Q43021628 | Therapeutic Modalities of Exudative Age-related Macular Degeneration. |
| Q33959341 | Therapeutic action of the mitochondria-targeted antioxidant SkQ1 on retinopathy in OXYS rats linked with improvement of VEGF and PEDF gene expression |
| Q42115589 | Thrombin-induced VEGF expression in human retinal pigment epithelial cells |
| Q28202192 | Transforming growth factor-beta regulates stearoyl coenzyme A desaturase expression through a Smad signaling pathway |
| Q44623709 | Transforming growth factor‐β induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: Involvement of mitogen‐activated protein kinases |
| Q48152882 | Treat-and-extend versus every-other-month regimens with aflibercept in age-related macular degeneration. |
| Q54571267 | Triple combination therapy and zeaxanthin for the treatment of neovascular age-related macular degeneration: an interventional comparative study and cost-effectiveness analysis. |
| Q36659533 | Two Different Doses of Intravitreal Bevacizumab for Treatment of Choroidal Neovascularization Associated with Age-related Macular Degeneration |
| Q50482167 | Two-year results of combined intravitreal ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy. |
| Q86551292 | Two-year results of combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation |
| Q37582957 | VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration. |
| Q37734665 | Vandetanib and ADAM inhibitors synergistically attenuate the pathological migration of EBV-infected retinal pigment epithelial cells by regulating the VEGF-mediated MAPK pathway |
| Q36908876 | Vascular endothelial growth factor A polymorphisms and age-related macular degeneration: a systematic review and meta-analysis |
| Q44386990 | Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells |
| Q36835234 | Vascular endothelial growth factor: biology and therapeutic applications |
| Q37834016 | Vascular endothelial growth factors in retinal and choroidal neovascular diseases |
| Q37487873 | Visual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosis |
| Q35476986 | Vitamin D deficiency in neovascular versus nonneovascular age-related macular degeneration |
| Q61448666 | Whole-genome methylation profiling of the retinal pigment epithelium of individuals with age-related macular degeneration reveals differential methylation of the SKI, GTF2H4, and TNXB genes |
Search more.